A boost from COVID-19 treatment sales helped bush Pfizer to a better-than-expected third quarter and higher forecast for the year.

Paxlovid can prevent hospitalization and death from COVID-19, but experts say it's being underused.

Pfizer lost more than $2 billion in the third quarter as an expected COVID-19 product sales decline clipped revenue.

The COVID-19 treatments millions of have taken for free from the federal government will enter the private market next week with a hefty price tag.

Crumbling COVID-19 vaccine and treatment sales chopped Pfizer’s second-quarter earnings, but both the drugmaker and Wall Street expect a rebound in the back half of 2023.

U.S. health regulators have given full approval to Pfizer’s COVID-19 pill Paxlovid.

U.S. health advisersare backing the continued use of Pfizer’s COVID-19 pill Paxlovid, saying it remains an important option for adults at high risk of severe illness.

Pfizer surprised Wall Street on Tuesday by predicting bigger-than-expected sales drops this year for two key products: its COVID-19 vaccine and treatment.

Pfizer’s COVID-19 pill appears to provide little or no benefit for younger adults.

President Joe Biden's doctor says the 79-year-old president has tested negative for COVID-19 but will continue to isolate at the White House until a second negative test.

Earlier this week, President Joe Biden said while he was diagnosed with COVID-19.

President Joe Biden's physician, Dr. Kevin O'Connor, says Biden continues to “improve significantly” despite a lingering sore throat.

President Joe Biden is reporting a runny nose, fatigue and an occasional dry cough from his COVID-19 infection.

President Joe Biden tested positive for COVID-19 on Thursday and is experiencing “very mild symptoms,” underscoring the persistence of the highly contagious virus as new variants challenge the nation’s efforts to resume normalcy after two and a half years of pandemic disruptions.

U.S. pharmacists can now prescribe the leading COVID-19 pill directly to patients.

The White House has announced more steps to make the antiviral treatment Paxlovid more accessible across the U.S. as it projects COVID-19 infections will continue to spread over the summer travel season.

The head of the World Health Organization has called on Pfizer to make its COVID-19 treatment more widely available in poorer countries.

A small number of COVID-19 patients are relapsing after taking Pfizer's antiviral pill, raising questions about the drug at the center of the U.S. response effort.

COVID-19 patients have two treatment options that can be taken at home.

President Joe Biden’s administration is taking steps to expand availability of the life-saving COVID-19 antiviral treatment Paxlovid.

President Joe Biden and his administration want Americans and their doctors to know that the country has an ample supply of the life-saving COVID-19 antiviral treatment Paxlovid and that it no longer needs to be rationed.

COVID-19 patients now have new treatments they can take at home to stay out of the hospital — if doctors get the pills to them fast enough.

Pfizer’s new COVID-19 treatment came with a catch when it debuted late last year: It can take months to make the tablets.

COVID-19 vaccine sales boosted Pfizer earnings well past fourth-quarter expectations, but the drugmaker has set a lower-than-expected bar for 2022.

South Korea has received its first supply of Pfizer’s antiviral COVID-19 pills to treat patients with mild or moderate symptoms.

Israel has approved a fourth vaccine dose for people most vulnerable to COVID-19, becoming one of the first countries to do so as it braces for a wave of infections fueled by the omicron variant.

Walmart and Sam’s Club pharmacies announced Thursday that they will begin dispensing the authorized COVID antiviral medication, Paxlovid and Molnupiravir, in Texas.

Newly infected COVID-19 patients have two new treatment options that can be taken at home.

Two antiviral pills are the latest additions to the handful of therapies to treat COVID-19 in the U.S. The Food and Drug Administration authorized the drugs from Merck and Pfizer as the first treatments that patients can take at home to treat mild-to-moderate symptoms.

The U.S. has authorized the first pill against COVID-19, a Pfizer drug that Americans can take at home to reduce the risk of hospitalization and death.